Strasbourg, France, July 16-20, 2025 – The Society of Robotic Surgery (SRS) conference, the most influential academic event in the field of robotic surgery, was held grandly in Strasbourg, France. Experts and scholars from over 30 countries gathered to explore future trends and technological innovations in robotic surgery.

As a representative Chinese enterprise with truly independent and original surgical robotics technology, Surgerii Robotics was invited to showcase its snake-shaped arm single-port surgical robot platform once again at the conference. During the event, Surgerii Robotics formally signed a long-term strategic cooperation agreement with IRCAD, the world's premier robotic surgery training center.

This landmark partnership marks a crucial step in Surgerii Robotics' accelerated global strategic expansion, injecting strong momentum into its deepening international market development.

Center Stage: China's "Snake-Shaped Arm" Technology Stuns at SRS Main Forum

Throughout the four-day conference, Surgerii Robotics captured global attention with its cutting-edge technological capabilities and increasingly extensive clinical experience. Professor Xu Kai, Founder of Surgerii  Robotics and Professor at Shanghai Jiao Tong University, attended the main conference and roundtable forums as a distinguished guest. He engaged in high-level dialogues with leading robotic experts, company founders, and investors from Europe, America, and Asia on topics including the global surgical robotics market landscape, technological innovation trends, regulatory challenges, and prospects for collaboration.

Professor Xu Kai presented China's independently developed single-port surgical robot to experts from around the world, sending a clear signal: Chinese technological prowess is no longer merely catching up; it has now taken a place at the forefront of innovation.

During the conference, globally renowned experts delivered in-depth presentations on the breakthrough applications of the   Surgerii snake-shaped arm surgical robotic system at the SRS Main Forum,Professor Diego Gonzalez Rivas, an international authority in thoracic surgery, Professor Wang Linhui, Director of Changhai Hospital (Urology), Professor Yan Zhilong,and Dr. Liu Pengtao from Shanghai Children’s Medical Center, Dr. Wang Jun, Director of Nanjing Children's Hospital.

Their presentations focused on the system's use in thoracic surgery, adult urology, and pediatric surgery. The experts highlighted Surgerii Robotics' core technological strengths and clinical performance, particularly emphasizing its: Exceptional multi-directional maneuverability through ultra-miniaturized incisions. Superb instrument mobility and precision demonstrated within confined surgical spaces.These groundbreaking capabilities sparked rapt attention and widespread acclaim among the international audience.

Strategic Milestone: Surgerii® Robotics Establishes Presence at France's IRCAD, Deepening Global Partnership

Beyond its participation in the SRS main forum,   Surgerii® Robotics was invited to multiple specialized forums hosted by IRCAD France and showcased its robotic platform and latest clinical outcomes at the IRCAD headquarters. Recognized as one of the world's most influential minimally invasive surgery education centers, IRCAD is acclaimed as the "Global Cradle of Minimally Invasive Surgery Training." Annually attracting over ten thousand surgeons from more than 100 countries, it serves as a vital international hub for disseminating and exchanging advanced surgical techniques.

On the morning of July 17th,   Surgerii® Robotics and IRCAD held an official signing ceremony in Strasbourg, formalizing a long-term strategic partnership. As part of this agreement,   Surgerii® will deploy a snake-shaped arm single-port surgical robot at the IRCAD headquarters. This system will be dedicated to surgeon training, scientific research, and international course demonstrations.

This marks a historic achievement: it will be the first Chinese-developed single-port surgical robot permanently stationed at IRCAD. This signifies the first systematic integration of original Chinese technology into a premier global training ecosystem, infusing surgical robotics education with Chinese innovation.

Through this collaboration, the   Surgerii® robot will not only work with IRCAD to promote standardized training and integration of surgical robotic technology into global clinical practice, but also leverage IRCAD's international platform to build a bridge connecting Chinese and global surgeons, research institutions, and clinical teams. This will further enhance medical technology exchanges between China and Europe, increase the international visibility and influence of China's original medical technologies, and drive the establishment of a truly multi-center, cross-regional, and sustainable global cooperation network.

Professor Jacques Marescaux, founder of IRCAD and a globally renowned expert in minimally invasive surgery, also delivered remarks at the signing ceremony: 'We have always been committed to incorporating the most groundbreaking surgical technologies into the global training system. Shuren's innovations in single-port robotic surgery are remarkable, and we look forward to this Chinese-developed robot playing an important role at IRCAD.'

Professor Xu Kai, founder of Shurui® Robotics, stated at the signing ceremony: 'IRCAD is a global authority platform for surgical education and minimally invasive innovation. We are very pleased to bring Shurui's advanced technology into the training system of international doctors through this cooperation. This is not only an important step in our company's global strategic layout but also a key milestone for Chinese original medical technology to enter the mainstream international system.'

Crossing boundaries, moving towards the global stage—SureRobotics enters a new phase of internationalization

With its successful debut at the recent SRS conference and the formal establishment of strategic cooperation with IRCAD, SureRobotics has clearly defined its strategic path on the global surgical robotics map. From multi-center clinical studies in Asia to deep deployment on Europe's top training platforms, SureRobotics is steadily expanding the global influence of domestically produced surgical robots through continuous technological innovation and international cooperation.

In the future, the ShuRui® robot will continue to uphold its mission of 'extending surgical boundaries through technology,' deeply advancing clinical research on serpentine-arm single-port technology, surgeon training, and global market expansion, striving to bring advanced ultra-minimally invasive treatment solutions to patients worldwide, and building a sustainable, shareable international medical innovation network.